Our results are in line with a study by Garacia Robles et al. that suggests the minor allele G in the ADIPQ gene polymorphism rs266729 constitutes a risk factor for the development of MetS [10], and a study by Smetnev et al. that reports the SNP rs266729 of the ADIPOQ gene are significantly associated with cardiovascular and metabolic diseases [14]. Here, ADIPOQ is linked to metabolic disease.